|
|
||||||||
After standardization for age and menopausal status, the prevalence of estrogen receptor positivity among 88 White breast cancer patients was about .72 compared with a prevalence of about .54 among Black patients. The prevalence of progesterone receptor positivity was also higher among White than among Black patients, although the magnitude of the difference was smaller. These differences were unchanged after adjustment for tumor size and nodal and distant metastases in addition to age and menopausal status.
This article has been cited by other articles:
![]() |
I. Poola, S. A.W. Fuqua, R. L. De Witty, J. Abraham, J. J. Marshallack, and A. Liu Estrogen Receptor {alpha}-Negative Breast Cancer Tissues Express Significant Levels of Estrogen-Independent Transcription Factors, ER{beta}1 and ER{beta}5: Potential Molecular Targets for Chemoprevention Clin. Cancer Res., October 15, 2005; 11(20): 7579 - 7585. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Marchbanks, J. A. McDonald, H. G. Wilson, S. G. Folger, M. G. Mandel, J. R. Daling, L. Bernstein, K. E. Malone, G. Ursin, B. L. Strom, et al. Oral Contraceptives and the Risk of Breast Cancer N. Engl. J. Med., June 27, 2002; 346(26): 2025 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Miller, B. F. Hankey, and T. L. Thomas Impact of Sociodemographic Factors, Hormone Receptor Status, and Tumor Grade on Ethnic Differences in Tumor Stage and Size for Breast Cancer in US Women Am. J. Epidemiol., March 15, 2002; 155(6): 534 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Dignam Efficacy of Systemic Adjuvant Therapy for Breast Cancer in African-American and Caucasian Women J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 36 - 43. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |